Medtronic, Wright Medical, RTI Surgical & more: 17 key notes

Written by Anuja Vaidya | February 26, 2016 | Print  |

Here are 17 key notes on orthopedic and spine device companies over the past week.

Anika Therapeutics will enter into an accelerated share repurchase program.

Bioventus entered into a multi-year agreement with Institut Biochimique SA, a Swiss pharmaceutical company, for exclusive distribution rights in the United States to the GELSYN-3.


CoNextions Medical will introduce its next-generation tendon repair technology, CoNextions TR, at the AAOS 2016 Annual Meeting.


Globus Medical reported net income in 2015 at $112.8 million, up from $92.5 million in 2014.


InVivo Therapeutics will hold its first symposium at the 2016 Spine Summit meeting on March 17 in Orlando, Fla.


InVivo Therapeutics enrolled a sixth patient into the INSPIRE Study.


Leader Biomedical launched its OssGro range of synthetic grafts.

Lucideon, the international materials technology company, added accelerated aging of ultra-high-molecular-weight polyethylene polymer orthopedic implants to its range of wear and fatigue testing services.

Maxx Orthopedics partnered with Invibio Knees to develop a PEEK-OPTIMA femoral knee replacement product.


Fortune named Medtronic to its 2016 "World's Most Admired Companies" list.

On Feb. 19, the FDA's orthopedic and rehabilitation devices advisory panel voted against the recommendation of Medtronic's Diam spinal stabilization implant.


Orthofix released the results of its study on the effect of pulsed electromagnetic field therapy on gene expression of intervertebral discs cells in normal and inflammatory environments.


OrthoGrid Systems released its new HipGrid Drone.


OrthoGrid Systems will offer new technology to address C-arm distortion and magnification at the American Academy of Orthopaedic Surgeons 2016 Annual Meeting.


RTI Surgical launched the Unison-C System, an anterior cervical fixation system.

United Orthopedic is now enrolling patients in its follow-up study of the U-Motion II+ Acetabular System and UTF Reduced Stem in patients receiving primary total hip arthroplasty.

Wright Medical Group's net sales for the fourth quarter of 2015 hit $177 million.


More articles on devices:
6 things to know about Johnson & Johnson's stock: Is there long-term strength?
Pacira's 2015 revenue hits $249M: 5 things to know
Fidia Farmaceutici to introduce treatment for OA-related knee pain — 5 things to know

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months